Mostrar el registro sencillo del ítem

dc.contributor.authorEscribano, Begoña M.
dc.contributor.authorAgüera Carmona, Eduardo
dc.contributor.authorAguilar-Luque, Macarena
dc.contributor.authorLuque, Evelio
dc.contributor.authorFeijóo, Montserrat
dc.contributor.authorLatorre, Manuel
dc.contributor.authorGiraldo, Ana I.
dc.contributor.authorGalván-Jurado, A.
dc.contributor.authorCaballero-Villarraso, Javier
dc.contributor.authorGarcía-Maceira, Fé I.
dc.contributor.authorSantamaría, Abel
dc.contributor.authorTúnez, Isaac
dc.date.accessioned2024-02-06T11:44:47Z
dc.date.available2024-02-06T11:44:47Z
dc.date.issued2018
dc.identifier.issn2214-9414
dc.identifier.urihttp://hdl.handle.net/10396/27164
dc.descriptionEmbargo hasta 06/02/2044
dc.description.abstractS-allyl cysteine (SAC), has shown itself to performance important activity as a neuroprotective agent. This action is prompted by antioxidative activity. The aim of this study was to evaluate the neuroprotective effect of SAC, the principal organosulfur compound of garlic, on experimental autoimmune encephalomyelitis (EAE) as a model of multiple sclerosis (MS). Young-adult Dark Agouti rats were used. The experimental model of EAE was carried out by means of mielyn oligodendrocyte glycoprotein (MOG). The effects of MOG were evaluated by changes in: clinical score, biomarkers of oxidative/nitrosative stress, antioxidants, mitochondrial viability and neurohistologic viability. Our results reveal that MOG causes oxidative/nitrosative damage in brain and spinal cord, a decrease in the glutathione redox system and cell loss, whereas SAC administration attenuates the effects of MOG. In addition, SAC was the most effective treatment used in this study. The data show the ability of SAC to modify the development of EAE.es_ES
dc.format.mimetypeapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/es_ES
dc.sourceJournal of Functional Foods, Vol 42, pp 281-288 (2018)es_ES
dc.subjectS-allyl cysteinees_ES
dc.subjectCell damagees_ES
dc.subjectExperimental autoimmune encephalomyelitises_ES
dc.subjectMultiple sclerosises_ES
dc.subjectOxidative damagees_ES
dc.titleNeuroprotective effect of S-allyl cysteine on an experimental model of multiple sclerosis: Antioxidant effectses_ES
dc.typeinfo:eu-repo/semantics/article
dc.relation.publisherversionhttps://doi.org/10.1016/j.jff.2017.12.068es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/embargoedAccesses_ES
dc.date.embargoEndDateinfo:eu-repo/date/embargoEnd/2044-02-06


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem